We're #hiring a new Regulatory Affairs Associate (Medical Device Labeling) in Santa Clara, California. Apply today or share this post with your network.
Viltis
Biotechnology Research
San Diego, California 16,026 followers
Driving Innovation. Delivering Results. Transforming Life Sciences.
About us
We are a consultancy dedicated to crafting personalized resource solutions exclusively for pharmaceutical, biotechnology, medical device, and diagnostics companies. Our core mission is to provide expert solutions to organizations grappling with resource challenges, all while making a meaningful impact on the lives of our consultants. Over the years, our consultants, operating under the Viltis banner, have consistently delivered innovative solutions to some of the industry's largest and most renowned enterprises.
- Website
-
http://www.viltis.com
External link for Viltis
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- San Diego, California
- Type
- Privately Held
- Founded
- 2020
- Specialties
- Life Sciences, Consulting, Recruiting, Scientific, Quality, Engineering, Clinical, Regulatory, Biologics, Medical Device, Pharmaceutical, and IVD
Locations
-
Primary
Get directions
424 15th St
3111
San Diego, California 92101, US
Employees at Viltis
Updates
-
Through its recently unveiled Priority Voucher program, the FDA seeks to accelerate the review process for companies that promise to keep prices down. https://lnkd.in/gsXK_8Nv
-
Viltis reposted this
Life Sciences Professional | Biotechnology | Medical Device | Pharmaceutical | Consulting
🔬 Private equity doubles down on biopharma: Bain Capital, Kohlberg & Mubadala lead a new multibillion-dollar investment in PCI Pharma Services 🧪 This marks a major milestone in biopharma services—PCI is now valued at $10 billion, supporting nearly 25% of the top 200 drugs and over 2,300 candidates in development, including GLP‑1 weight‑loss and cancer therapies Financial Time For biopharma leaders, this signals growing demand for scalable, end-to-end service providers. Highlights how AI-driven innovation isn’t just theoretical—it’s reshaping real-world platforms like PCI. Curious how this trend reshapes CDMO demand, M&A dynamics, and the AI‑biopharma value chain? Let’s discuss! Viltis MedMind
This content isn’t available here
Access this content and more in the LinkedIn app
-
We're #hiring a new Clinical Data Manager (Medical Devices) – Onsite in Maple Grove, Minnesota. Apply today or share this post with your network.
-
We're #hiring a new Clinical Data Manager in Maple Grove, Minnesota. Apply today or share this post with your network.
-
We're #hiring a new Clinical Data Coordinator in Maple Grove, Minnesota. Apply today or share this post with your network.
-
President Donald Trump provided a tariff update Tuesday, saying that imported pharmaceutical products could be subject to 200% levies, according to reporting from multiple outlets. https://lnkd.in/gXnu-n9j
-
We're #hiring a new Clinical Data Coordinator in Maple Grove, Minnesota. Apply today or share this post with your network.
-
President Donald Trump’s One Big Beautiful Bill, signed into law last week, reintroduces broader exemptions for orphan drugs from the IRA’s drug price negotiation program—a move welcomed by the biopharma industry. The new tax law also cuts Medicaid funding, posing a minimal risk to pharma’s bottomlines and potentially jeopardizing hospitals’ 340B status. It does not, however, include new rules for pharmacy benefit managers that had been in an earlier draft. https://lnkd.in/gFaASksN
-
We're #hiring a new Embedded Systems Test Engineer – Medical Devices in Plano, Texas. Apply today or share this post with your network.